What is the current Price Target for the Achieve Life Sciences, Inc. stock?

The average Achieve Life Sciences, Inc. target price is $12.75. This is 59.77% higher than the current stock price. The highest price target is 176.32%, the lowest is 13.91%. 14 Analysts have issued a price target Achieve Life Sciences, Inc. 2027 .

How high will the Achieve Life Sciences, Inc. stock rise?

No reliable answer can be given as to how high the Achieve Life Sciences, Inc. stock will rise. The performance of stocks, including the Achieve Life Sciences, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Achieve Life Sciences, Inc. stock today?

The performance of Achieve Life Sciences, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Achieve Life Sciences, Inc. stock fall?

The decline in Achieve Life Sciences, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Achieve Life Sciences, Inc. Forecast, price target & analysts

$7.98

0.89%

Nasdaq, Sep 18, 04:01 pm EDT. Closed.

ISIN

US0044682039

Symbol

ACHV

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Achieve Life Sciences, Inc. Target price 2026 - Analyst rating & recommendation

Achieve Life Sciences, Inc. Classifications & Recommendation

Buy

94%

Hold

Achieve Life Sciences, Inc. Price Target

Target Price	$12.75
Price	$7.98
Potential	59.77% register free of charge
Number of Estimates	14

	14 Analysts have issued a price target Achieve Life Sciences, Inc. 2027 . The average Achieve Life Sciences, Inc. target price is $12.75. This is 59.77% register free of charge higher than the current stock price. The highest price target is $22.05 176.32% register free of charge , the lowest is $9.09 13.91% register free of charge .
	A rating was issued by 17 analysts: 16 Analysts recommend Achieve Life Sciences, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Achieve Life Sciences, Inc. stock has an average upside potential 2027 of 59.77% register free of charge . Most analysts recommend the Achieve Life Sciences, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
Earnings Per Share $	-1.25	-1.32
	0.81%	5.60%
P/E		negative

14 Analysts have issued a Achieve Life Sciences, Inc. forecast for earnings per share. The average Achieve Life Sciences, Inc. EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2025	$-1.25	0.81%
2026	$-1.32 5.60% unlock
2027	$-0.67 49.24% unlock
2028	$0.14 120.90% unlock
2029	$1.19 750.00% unlock
2030	$2.21 85.71% unlock
2031	$3.30 49.32% unlock
2032	$4.15 25.76% unlock
2033	$5.38 29.64% unlock

Current	-6.54	209.88%
2026	-5.98 8.52% unlock
2027	-11.77 96.82% unlock
2028	58.16 594.14% unlock
2029	6.66 88.55% unlock
2030	3.58 46.25% unlock
2031	2.40 32.96% unlock
2032	1.90 20.83% unlock
2033	1.47 22.63% unlock

Achieve Life Sciences, Inc....

Current Achieve Life Sciences, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Morgan Stanley	Locked ➜ Locked	Locked	Aug 13 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jun 22 2026
Canaccord Genuity	Locked ➜ Locked	Locked	Apr 21 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Apr 16 2026
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 25 2026
Citizens	Locked ➜ Locked	Locked	Nov 25 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 21 2025

Analyst Rating	Date
Locked Morgan Stanley: Locked ➜ Locked	Aug 13 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Jun 22 2026
Locked Canaccord Genuity: Locked ➜ Locked	Apr 21 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Apr 16 2026
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 25 2026
Locked Citizens: Locked ➜ Locked	Nov 25 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 21 2025

Discover more stocks with a high price target

NIO ADR 100.10%

Alibaba Group Holding Ltd 68.75%

Infineon 65.25%

Tencent Holdings Ltd. 63.10%

Rheinmetall 61.30%

TUI 56.70%

Adyen 53.16%

Siemens Energy 49.14%

Adidas 46.64%

Uber Technologies 46.13%

BYD 40.95%

NVIDIA 37.67%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now